IL6 and diabetes mellitus: Many studies show that IL-6 gene promoter polymorphism (rs1800795G > C) is associated with the risk for developing both neoplastic and non-neoplastic diseases, including Kaposi sarcoma, intracranial hemorrhage, diabetes mellitus, osteoporosis, and Crohn’s disease [43,44,45,46,47].